Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suk See De Ravin

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Science Translational Medicine|April 22, 2016
Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiencySuk See De Ravin, Xiaolin Wu, Susan Moir, et al.
Nature|April 22, 2025
Custom CRISPR-Cas9 PAM variants via scalable engineering and machine learningRachel A Silverstein, Nahye Kim, Ann-Sophie Kroell, et al.
Blood Advances|December 7, 2020
NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous diseaseSuk See De Ravin, Julie Brault, Ronald J Meis, et al.
The New England Journal of Medicine|October 15, 2025
Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase DeficiencyClaire Booth, Katelyn Masiuk, Konstantinos Vazouras, et al.
Science Translational Medicine|February 7, 2024
Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiencyMaria Carmina Castiello, Chiara Brandas, Samuele Ferrari, et al.
The New England Journal of Medicine|April 18, 2019
Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1Ewelina Mamcarz, Sheng Zhou, Timothy Lockey, et al.
Blood|May 11, 2021
Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiencyBryanna Reinhardt, Omar Habib, Kit L Shaw, et al.
The New England Journal of Medicine|December 8, 2025
Prime Editing for p47<sup>phox</sup>-Deficient Chronic Granulomatous DiseaseJennifer L Gori, Elie Haddad, Haydar Frangoul, et al.
Blood|January 29, 2021
Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of functionJahnavi Aluri, Alicia Bach, Saara Kaviany, et al.
Nature Medicine|January 29, 2020
Lentiviral gene therapy for X-linked chronic granulomatous diseaseDonald B Kohn, Claire Booth, Elizabeth M Kang, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Science Translational Medicine|April 22, 2016
Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiencySuk See De Ravin, Xiaolin Wu, Susan Moir, et al.
Nature|April 22, 2025
Custom CRISPR-Cas9 PAM variants via scalable engineering and machine learningRachel A Silverstein, Nahye Kim, Ann-Sophie Kroell, et al.
Blood Advances|December 7, 2020
NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous diseaseSuk See De Ravin, Julie Brault, Ronald J Meis, et al.
The New England Journal of Medicine|October 15, 2025
Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase DeficiencyClaire Booth, Katelyn Masiuk, Konstantinos Vazouras, et al.
Science Translational Medicine|February 7, 2024
Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiencyMaria Carmina Castiello, Chiara Brandas, Samuele Ferrari, et al.
The New England Journal of Medicine|April 18, 2019
Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1Ewelina Mamcarz, Sheng Zhou, Timothy Lockey, et al.
Blood|May 11, 2021
Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiencyBryanna Reinhardt, Omar Habib, Kit L Shaw, et al.
The New England Journal of Medicine|December 8, 2025
Prime Editing for p47<sup>phox</sup>-Deficient Chronic Granulomatous DiseaseJennifer L Gori, Elie Haddad, Haydar Frangoul, et al.
Blood|January 29, 2021
Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of functionJahnavi Aluri, Alicia Bach, Saara Kaviany, et al.
Nature Medicine|January 29, 2020
Lentiviral gene therapy for X-linked chronic granulomatous diseaseDonald B Kohn, Claire Booth, Elizabeth M Kang, et al.
Pageof 7